Analyst Coverage and Consensus

DISCLAIMER
doValue shares are covered by the analysts listed below.
The consensus table reports figures computed as the median of the most recent estimates by some of the mentioned analysts on the main financial data of doValue S.p.A..
 
Consensus information included in this page is presented for information purposes only and do not constitute a recommendation or offer to purchase, hold or sell doValue shares.
Such information represents estimates by the mentioned independent analysts and do not represent opinions, estimates or forecasts of doValue S.p.A. or members of its management.
 
By including this information on its website, doValue does not share nor concur to the forming of opinions, estimates or forecasts presented in this page and declines responsibility with regards to the accuracy, completeness and or correctness of such information.
 

RECOMMENDATIONS





ANALYST COVERAGE
 

Broker	Analyst	E-mail	Telephone	Target Price (€)	Rating	Last Modified
AXIA Ventures Group	Jonas S. Floriani	Jonas.Floriani@Axiavg.com	+44 20 8068 3516	12,1	Buy	14/01/2021
Banca Akros	Luigi Tramontana	luigi.tramontana@bancaakros.it	+39 02 4344 4239	11,5	Accumulate	03/02/2021
Berenberg	Andreas Markou	andreas.markou@berenberg.com	+44 20 3753 3022	10,0	Buy	06/08/2020
Citi	Borja Ramirez	borja.ramirez@citi.com	+44 20 7508 0206	10,5	Buy	10/07/2020
Equita SIM	Andrea Lisi	a.lisi@equitasim.it	+39 026204275	11,0	Buy	07/08/2020
Intermonte SIM	Christian Carrese Nicholas Binda	christian.carrese@intermonte.it, nicholas.binda@intermonte.it	+39 02 77115 485 +39 02 77115 422	11,9	Outperform	02/02/2021
JP Morgan	Julia Varesko	julia.varesko@jpmorgan.com	+44 20 3493 0551	11,60	Buy	05/11/2020
Kepler Cheuvreux	Filippo Prini	fprini@keplercheuvreux.com	+39 02 8550 7226	10,5	Buy	06/08/2020
Bestinver Securities	Pietro Solidoro	psolidoro@bestinver.es	+39 02 982880205	10-11	Buy	26/02/2021

  

ANALYSTS' CONSENSUS
 

€m	2017A	2018A	2019A	2020E	2021E	2022E	N. of estimates 2022
Gross Revenues	213	234	364	399	527	566	8
Net Revenues	195	210	324	357	480	503	8
EBITDA ex NRI	70	84	140	124	196	220	7
EBITDA margin	33%	36%	39%	31%	37%	39%	7
EBITDA	70	81	128	114	193	221	7
EBIT	68	80	78	32	111	141	8
Net Income ex NRI	45	53	69	18	62	81	6
Net Income	45	51	41	7	62	81	8
Net Debt / (Net Cash)	- 39	- 68	237	384	281	168	6

Last update: February, 2021

Notes:
Non-recurring items (NRIs) mainly refer to costs connected with the acquisition of Altamira Asset Management and Eurobank FPS (now doValue Greece), included in operating costs, as well as termination incentive plans and non-cash DTA reassessment costs.